Internal Medicine, Rheumatology · Amarillo, TX
NPI
1457322869
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6842 Plum Creek Dr
Amarillo, TX, 79124
Phone (806) 353-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
289,238 services
Medicare patients, 2024
962
Average age 71
Drug cost, 2024
$5.6M
8,425 prescriptions
Company payments, 2025
$1,260
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Constantine K Saadeh was code J3262 (injection, tocilizumab, 1 mg), 52,233 times for 22 patients. In total Constantine K Saadeh billed 289,238 services in 202 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 52,233 | 22 | $4.69 | $245K |
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 24,780 | 15 | $13.97 | $346K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 23,450 | 48 | $33.40 | $783K |
| J2357 Injection, omalizumab, 5 mg | Office | 16,305 | 27 | $29.12 | $475K |
| 95165 Treatment - Miscellaneous | Office | 14,540 | 268 | $10.54 | $153K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 13,620 | 142 | $0.10 | $1,364 |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 11,134 | 18 | $9.13 | $102K |
| 95004 Test - Miscellaneous | Office | 10,080 | 113 | $2.59 | $26K |
| J0897 Injection, denosumab, 1 mg | Office | 8,580 | 87 | $20.21 | $173K |
| J9312 Injection, rituximab, 10 mg | Office | 5,480 | 20 | $57.93 | $317K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 5,100 | 23 | $24.49 | $125K |
| 95117 Treatment - Miscellaneous | Office | 3,014 | 141 | $8.10 | $24K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,544 | 31 | $0.22 | $571 |
| 99214 Office E&M - Established | Office | 2,149 | 795 | $90.26 | $194K |
| 85025 Blood Count | Office | 1,888 | 591 | $7.44 | $14K |
By year: 2022 $4.3M for 252,309 services; 2023 $4.9M for 271,763 services; 2024 $4.9M for 289,238 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,888 | 591 | $7.44 | $14K |
| 80053 Clinical Chemistry | 1,749 | 591 | $10.10 | $18K |
| 86140 Clinical Chemistry | 1,686 | 580 | $4.95 | $8,342 |
| 85652 Clinical Chemistry | 1,661 | 580 | $2.58 | $4,285 |
| 86235 Immunoassay | 1,460 | 158 | $17.19 | $25K |
| 36415 Venipuncture Blood Collection | 1,319 | 456 | $8.56 | $11K |
| 83516 Immunoassay | 433 | 128 | $11.12 | $4,814 |
| 86160 Immunoassay | 353 | 128 | $11.36 | $4,011 |
| 82306 Clinical Chemistry | 344 | 240 | $28.61 | $9,842 |
| 86038 Immunoassay | 285 | 198 | $11.48 | $3,272 |
Medicare prescription drug claims, 2024
In 2024, the drug Constantine K Saadeh prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 673 prescriptions and refills. In total Constantine K Saadeh wrote 8,425 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 673 | 673 | 97 | $21K |
| Hydroxychloroquine Sulfate Generic | 644 | 1,111 | 169 | $22K |
| Montelukast Sodium Generic | 417 | 823 | 112 | $3,693 |
| Methotrexate Methotrexate Sodium | 365 | 637 | 122 | $8,172 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 350 | 431 | 87 | $272K |
| Famotidine Generic | 341 | 570 | 84 | $4,443 |
| Gabapentin Generic | 255 | 322 | 63 | $3,828 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 208 | 263 | 100 | $6,408 |
| Prednisone Generic | 195 | 261 | 52 | $731 |
| Leflunomide Generic | 164 | 338 | 57 | $9,055 |
| Fluticasone Propionate Generic | 152 | 277 | 58 | $2,247 |
| Folic Acid Generic | 133 | 273 | 41 | $1,008 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 127 | 147 | 28 | $93K |
| Tramadol Hcl Generic | 117 | 122 | 36 | $1,599 |
| Sulfasalazine Generic | 116 | 198 | 34 | $3,490 |
Brand drugs: 2,199 claims; generic drugs: 6,206 claims; opioid claims: 844.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Constantine K Saadeh $1,260 ($1,260 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $314.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $314 |
| Amgen Inc. AMGN | 40 | $283 |
| Blueprint Medicines Corporation SNY | 4 | $102 |
| Sobi, Inc SOBI.ST | 2 | $66.47 |
| Ionis Pharmaceuticals, Inc. IONS | 2 | $62.31 |
| Grifols USA, LLC | 2 | $61.47 |
| UCB, Inc. UCB.BR | 3 | $52.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.8 |
| CSL Behring CSL.AX | 2 | $48.65 |
| TerSera Therapeutics LLC | 2 | $37.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.